The use of thymoquinone in nephrotoxicity related to acetaminophen

International Journal of Surgery

Volumn 13, Issue , 2015, Pages 33-37

  Aycan, Ilker Öngüç ^a   Tokgöz, Orhan ^a   Tüfek, Adnan ^a   Alabalik, Ulaş ^a   Evliyaoğlu, Osman ^a   Turgut, Hüseyin ^b   Çelik, Feyzi ^a   Güzel, Abdulmenap ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Obstetrics and Gynecology Hospital Department of Anaesthesiology and Reanimation   (Turkey)

Author keywords

Acetaminophen; Nephrotoxicity; Thymoquinone

Indexed keywords

CREATININE; MALONALDEHYDE; NITRIC OXIDE; PARACETAMOL; THYMOQUINONE; UREA; ANALGESIC AGENT; BENZOQUINONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; ANIMAL; BLOOD; DRUG EFFECTS; KIDNEY; WISTAR RAT;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; BENZOQUINONES; CREATININE; KIDNEY; MALE; RATS, WISTAR; UREA;

EID: 84921502589     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2014.11.020     Document Type: Article

References (23)

1. James L.P., Mayeux P.R., Hinson J.A. Acetaminophen-induced hepatotoxicity. Drug Metab. Dispos. 2003, 31:1499-1506.
2. American Association of Poison Control Centers Practice guideline: acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin. Toxicol. 2006, 44:1-18.
3. Wolf S.J., Heard K., Sloan E.P., Jagoda A.S., American College of Emergency Physicians Clinical policy: critical issues in the management of patients presenting to the emergency department with acetaminophen overdose. Ann. Emerg. Med. September 2007, 50:292-313.
4. Mazer M., Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J.Med. Toxicol. 2008, 4(1):2-6.
5. H. Jaeschke H, M.L. Bajt, Intracellular signaling mechanisms of acetaminophen-induced liver cell death, Toxicol. Sci. 89 31-41.
6. Nagi M.N., Almakki H.A., Sayed-Ahmed M.M., Al-Bekairi A.M. Thymoquinone supplementation reverses acetaminophen-induced oxidative stress, nitric oxide production and energy decline in mice liver. Food Chem. Toxicol. 2010, 48:2361-2365.
7. Nagi M.N., Mansour M.A. Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol. Res. 2000, 41:283-289.
8. Nagi M.N., Alam K., Badary O.A., Al-Sawaf H.A., Al-Bekairy A.M. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via antioxidant mechanism. Biochem. Mol. Biol. 1999, 47:153-159.
9. Aycan I.O., Tufek A., Tokgoz O., et al. Thymoquinone treatment against acetaminophen-induced hepatotoxicity in rats. Int. J. Surg. 2014, 12(3):213-218.
10. Badary O.A., Nagi M.N., Al-Shabanah O.A., Al-Sawaf H.A., Al-Sahaibani M.O., Al-Bekairi A.M. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can. J. Physiol. Pharmacol. 1997, 75:1356-1361.
11. Yildiz F., Coban S., Terzi A., et al. Nigella sativa relieves the deleterious effects of ischemia reperfusion injury on liver. World J. Gastroenterol. 2008, 14(33):5204-5209.
12. Alkharfy K.M., Al-Daghri M.A., Al-Attas O.S., Alokail M.S. The protective effect of thymoquinone against sepsis syndrome morbidity and mortality in mice. Int. Immunupharmacol. 2011, 11:250-254.
13. Badary O.A., Taha R.A., Gamal el-Din A.M., Abdel-Wahab M.H. Thymoquinone is a potent superoxide anion scavenger. Drug Chem. Toxicol. 2003, 26:87-98.
14. Yen F.L., Wu T.H., Lin L.T., Lin C.C. Hepatoprotective and antioxidant effects of Cuscuta chinensis against acetaminophen-induced hepatotoxicity in rats. J.Ethnopharmacol. 2007, 111:123-128.
15. Grees L.C., Wagner D.A., Glogowski J., et al. Analysis of nitrate, nitrite and 15N nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
16. Botsoglou N.A., Fletouris D.J., Papageorgiou G.E., Vassilopoulos V.N., Mantis A.J., Trakatellis A.G. Rapid, sensitive and specific thiobarbituric acid method for measuring lipid peroxidation in animal tissue, food and feedstuff samples. Agric. Food Chem. 1994, 42:1931-1937.
17. Tufek A., Tokgoz O., Aliosmanoglu I., et al. The protective effects of dexmedetomidine on the liver and remote organs against hepatic ischemia reperfusion injury in rats. Int. J. Surg. 2013, 11:96-100.
18. Mansour M.A., Nagi M.N., El-Khatib A.S., Al-Bekairi A.M. Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase in different tissues of mice: possible mechanism of action. Cell. Biochem. Funct. 2002, 20:143-151.
19. Blakely P., Mcdonald B.R. Acute renal failure due to paracetamol ingestion: a case report and review of the literature. J.Am. Soc. Nephrol. 1995, 6:48-53.
20. Pergener T.V., Whelton P.K., Klag M.J. Risk of kidney failure associated with the use of paracetamol, aspirin, and nonsteroidal antiinflammatory drugs. N.Engl. J. Med. 1994, 331:1675-1679.
21. Fored C.M., Ejerblad E., Lindblad P., et al. Acetaminophen, aspirin, and chronic renal failure. N.Engl. J. Med. 2001, 345:1801-1808.
22. Bessems J.G., Vermeulen N.P. Paracetamol-induced toxicity: molecular and biochemical mechanisms, analogues, and protective approaches. Rev. Toxicol. 2001, 31:55-138.
23. Mugford C.A., Tarloff J.B. The contribution of oxidation and deacetylation to acetaminophen nephrotoxicity in female Sprague-Dawley rats. Toxicol. Lett. 1997, 93:15-22.